Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Black Bird Biotech, Inc. (BBBT)

Compare
0.0001
+0.0001
(0.00%)
At close: April 4 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Fabian G. Deneault Chairman of the Board & President 90k -- 1967
Mr. William E. Sluss CFO, VP of Finance & Director 60k -- 1955
Mr. Eric Newlan Esq. VP, Secretary & Director 80k -- 1962
Mr. Nelson Grist Chief Executive Officer -- -- --
Mr. William J. LoBell Executive Vice President of Sales & Development -- -- 1948

Black Bird Biotech, Inc.

11961 Hilltop Road
Suite 22
Argyle, TX 76226
United States
833 223 4204 https://www.blackbirdbiotech.com
Sector: 
Healthcare

Description

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Argyle, Texas.

Corporate Governance

Black Bird Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 16, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

March 6, 2024 at 12:00 AM UTC

SC 14F1: Statement regarding change in majority of directors pursuant to Rule 14f-1

March 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 22, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 20, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 15, 2023 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

August 21, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 1, 2023 at 12:00 AM UTC

DEF 14C: Proxy Statements

May 22, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 11, 2023 at 12:00 AM UTC

PRER14C: Proxy Statements

Related Tickers